Quick answer
Weight gain and weight loss have both been reported during Cymbalta treatment. The label alone cannot show whether the medicine caused a particular person's weight change. If you notice a change, discuss it with your prescriber rather than stopping or changing duloxetine yourself. Cymbalta prescribing information.
Your concern deserves a clear conversation. You do not have to dismiss it because your medicine is helping, and you do not have to decide on your own that treatment must stop.
What the evidence actually says
Cymbalta is a brand of duloxetine. Its approved uses include depression, anxiety and certain pain conditions; weight management is not an approved indication. Its adult clinical-trial adverse-event listings include changes in weight in both directions. That is different from a prediction about what will happen to you. Product label.
A 2024 study compared weight changes among adults starting commonly used antidepressants using health records. Duloxetine was associated with slightly greater average weight gain than sertraline at six months. The study was observational, not a randomized assignment of treatment. Missing weight information, imperfect medication records and low adherence limit what it can establish. It does not tell an individual which antidepressant to take. Original study.
The practical conclusion is limited: a weight concern is reasonable to assess, but neither a label entry nor a population average proves the cause in one person.
Put the timing into context
Try to separate what you observed from what you suspect. “My clothes fit differently after I started treatment” is an observation. “The medicine is the only cause” is a conclusion that needs assessment.
Weight can be affected by medicines, health conditions, sleep and other circumstances. Tell your prescriber about changes in those areas, including changes that happened before duloxetine. NIDDK on factors affecting weight.
Do not dismiss symptoms because the number on the scale seems small. Explain what is worrying you and how it affects daily life. If weighing itself is distressing, ask for another way to discuss and monitor the concern.
Bring this review sheet to your appointment
| Topic | What to record |
|---|---|
| The change | Available measurements or what you noticed; avoid inventing missing numbers |
| The timeline | When treatment began and when you first noticed the change |
| Other treatment | All prescription medicines, nonprescription products and supplements |
| Symptoms | Appetite, sleep, digestive or mood changes you want to discuss |
| Benefits | What the treatment is helping with, if anything |
| Your priority | The question or concern you most want addressed |
Then ask: “Could we review the possible causes and decide what to monitor before changing treatment?” You can also ask who will coordinate follow-up if more than one clinician prescribes your medicines.
Do not stop duloxetine suddenly
Stopping duloxetine without medical guidance can cause discontinuation symptoms. MedlinePlus lists symptoms including dizziness, nausea, anxiety and sleep difficulties. If a treatment change is appropriate, your prescriber should guide it. A weight article is not a tapering plan. MedlinePlus duloxetine guidance.
Contact your prescriber right away for new or worsening depression or unusual mood or behavior changes. MedlinePlus duloxetine warning. If you are having suicidal thoughts, call or text 988 in the United States; call 911 in a life-threatening emergency. NIMH crisis guidance.
Related reading
Educational information only. This article does not recommend a medication, diagnosis or change to your treatment. Sources checked September 28, 2026.
Frequently Asked Questions
Does everyone gain weight on Cymbalta?
No. Weight changes have been reported in both directions. The available evidence cannot predict an individual person's response. Tell your prescriber what you notice.
Can Cymbalta also cause weight loss?
Weight loss is among the reported changes. Unwanted weight loss should also be discussed, especially if you are struggling to eat. It is not a reason to use duloxetine for weight management.
Will my weight return to normal if treatment changes?
That cannot be promised. First clarify possible causes and what “normal” means for you with your clinician. Do not stop treatment to test the theory yourself.
Should I switch to another antidepressant?
An online comparison cannot answer that safely. Your prescriber needs to consider why the medicine was prescribed, its benefits, side effects, other treatments and your preferences.
Should I add a weight-loss medicine?
This article does not recommend adding one. Bring the concern to your clinician for an overall assessment rather than treating a suspected side effect with another prescription on your own.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.Factors Affecting Weight & Health · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 2.Cymbalta Prescribing Information (revised August 2023) · Eli Lilly and Company · accessed
- 3.Medication-Induced Weight Change Across Common Antidepressant Treatments: A Target Trial Emulation Study (2024) · Annals of Internal Medicine, American College of Physicians · accessed
- 4.Duloxetine: Patient Medication Information · American Society of Health-System Pharmacists, via MedlinePlus · accessed
- 5.Suicide Prevention: Help and Crisis Resources · National Institute of Mental Health (NIMH) · accessed
Telehealth prescribing rules differ by state. Read the state-by-state guide.
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them